Preprint
Review

This version is not peer-reviewed.

Shugoshin: From a Perspective of Clinical Disorders

A peer-reviewed version of this preprint was published in:
BioChem 2021, 1(2), 51-59. https://doi.org/10.3390/biochem1020006

Submitted:

24 March 2021

Posted:

25 March 2021

You are already at the latest version

Abstract
Proper and timely segregation of cellular genome is an important and a prime requirement of all cell division programmes. Mis-segregation of chromosomes and resulting aneuploidy leads to several clinical consequences. Over the years, shugoshin emerges as a key protein factor involved in the segregation of genetic material in dividing cells. Deletion or altered level of shugoshin is reported in several human malignancies, as a result, shugoshin now emerges as an important tumour associated gene and a possible target for cancer therapy. Apart from the role in cancer, recent studies also showed the involvement of shugoshin in several other clinical disorders. Through this review, we tried to highlight the clinical relevance of shugoshin.
Keywords: 
;  ;  ;  ;  
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.